Dimofte Florentin, Dimofte Cristina, Ungurianu Sorin, Serban Cristina, Țocu George, Cârneciu Nicoleta, Filip Iulia, Bezman Laura, Ciuntu Bogdan Mihnea, Abdulan Irina Mihaela, Mihailov Raul, Necula Radu Dan, Sabou Florin Lucian, Firescu Dorel
General Surgery Clinic, "St. Apostol Andrei" County Emergency Clinical Hospital, Strada Brăilei 177, 800578 Galati, Romania.
Department of Orthopedic, Faculty of Medicine, "Dunarea de Jos" University of Medicine and Pharmacy, 800008 Galati, Romania.
J Clin Med. 2024 Jul 9;13(14):4004. doi: 10.3390/jcm13144004.
Given the increasing rate of infections following hip arthroplasty, one of the current options is the application of a biocomposite at the site of the infection. One of the products used is Stimulan, a completely resorbable calcium sulfate, designed to treat acute and chronic infections. This biocomposite has a controlled purity, is easy to mix with liquid, powder, and antibiotics, and can be applied directly to the site of infection, or it can be injected. We analyzed data from 76 patients, who were admitted to the County Clinical Hospital of Emergency "St. Apostol Andrei" in Galati during January 2017-September 2023, with a diagnosis of infection associated with hip arthroplasty. In 69.73% of cases (52 patients), we decided to keep the implant in place. In this subgroup, Stimulan was applied in 26 cases (57.78%). Of these, 100% were cured-compared to the subgroup in which Stimulan was not applied, where this percentage was lower. All patients underwent chemical and mechanical toileting, and for 24 patients (20.27%), it was necessary to ablate the implant with or without the application of Stimulan, then reimplantation of the prosthesis. The patients with Stimulan had a longer average length of hospitalization, almost half of them required intervention in two periods, and a quarter required the implantation of spacers. However, the cure rate was higher, only in three people could we not control the infection, and there was no death. This study confirms the effectiveness of the treatment when using a biocomposite in addition to the classical treatment for both acute and chronic cases.
鉴于髋关节置换术后感染率不断上升,目前的选择之一是在感染部位应用生物复合材料。所使用的产品之一是Stimulan,一种完全可吸收的硫酸钙,旨在治疗急慢性感染。这种生物复合材料纯度可控,易于与液体、粉末和抗生素混合,可直接应用于感染部位,也可注射使用。我们分析了2017年1月至2023年9月期间入住加拉茨“圣使徒安德烈”县急诊临床医院的76例诊断为髋关节置换术相关感染患者的数据。在69.73%的病例(52例患者)中,我们决定保留植入物。在这个亚组中,26例(57.78%)应用了Stimulan。其中,100%治愈——与未应用Stimulan的亚组相比,该百分比更低。所有患者均接受了化学和机械清创,24例(20.27%)患者需要在应用或不应用Stimulan的情况下切除植入物,然后重新植入假体。应用Stimulan的患者平均住院时间更长,几乎一半的患者需要分两个阶段进行干预,四分之一的患者需要植入间隔物。然而,治愈率更高,只有3人感染未得到控制,且无死亡病例。这项研究证实了在急性和慢性病例的经典治疗基础上使用生物复合材料进行治疗的有效性。